Led by Santé, the funding will support completion of the world's first randomised HIFU trial for pancreatic cancer, and accelerate U.S. clinical programs for the company's anaesthesia-free, outpatient sonic therapy...
The 6F joins the company’s first two FDA-cleared catheters and broadens therapeutic options...
New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base...
The Breakthrough Device Designation is granted to medical technologies that have the potential to provide more effective treatment for life-threatening or irreversibly debilitating conditions...
This first-in-human implantation highlights how purpose-built technology can transform care for our smallest patients...
The Aperio GT Elite scanner establishes a new benchmark for high-throughput digital pathology research workflows...
This Photosonic technology enables a more precise definition of treatment areas...
Approval marks a historic milestone for Americans living with ssAR who are at high risk for surgery and previously had no dedicated transcatheter treatment option...
Innovative Investigational Ventricular Assist Device Marks Major Step Forward in Patient Care...
The technology is available on the new MyLabE85 GTS Edition that will be showcased together with the brand new MyLabC30 GTS ultrasound system at the Esaote booth...
